SEARCH

SEARCH BY CITATION

References

  • 1
    Schmotzer GL. Barriers and facilitators to participation of minorities in clinical trials. Ethn Dis. 2012; 22(2): 226230.
  • 2
    Census U. Most Children Younger Than Age 1 are Minorities, Census Bureau Reports 2012.
  • 3
    Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012; 307(5): 491497.
  • 4
    Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabet Care. 2009; 32(2): 287294.
  • 5
    Wendler D, Kington R, Madans J, Van Wye G, Christ-Schmidt H, Pratt LA, Brawley OW, Gross CP, Emanuel E. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006; 3(2): e19.
  • 6
    Streicher S, Sanderson S, Jabs E, Diefenbach M, Smirnoff M, Peter I, Horowitz CR, Brenner B, Richardson LD. Reasons for participating and genetic information needs among racially and ethnically diverse biobank participants: a focus group study. J Commun Genet. 2011; 2(3): 153163.
  • 7
    Sanderson S, Diefenbach M, Zinberg R, Horowitz CR, Smirnoff M, Zweig M, Streicher S, Jabs EW, Richardson LD. Willingness to participate in genomics research and desire for personal results among underrepresented minority patients: a structured interview study. J Commun Genet. 2013 Jun 22 [Epub ahead of print].
  • 8
    Freedman LS, Simon R, Foulkes MA, Friedman L, Geller NL, Gordon DJ, Mowery R. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 Äî The perspective of NIH clinical trialists. Controlled Clin Trials. 1995; 16(5): 277285.
  • 9
    Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, Sosa JA, Sumner AE, Anton B. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors–an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2012; 97(9): E15791639.
  • 10
    ResearchCenter P. Demographic Profile of Hispanics in Arizona, 2010. 2010; http://www.pewhispanic.org/states/state/az/ – note-1. Accessed May 3, 2012.
  • 11
    Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulinlamp.[see comment]. Diabet Care. 1999; 22(9): 14621470.
  • 12
    Phillips DI, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med. 1994; 11(3): 286292.
  • 13
    Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 1981; 68(6): 14561467.
  • 14
    Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112(17): 27352752.
  • 15
    Association AD. Diagnosis and classification of Diabetes Mellitus. Diabet Care. 2012; 35 (Suppl 1): S64S71.
  • 16
    Dankwa-Mullan I, Rhee KB, Stoff DM, Pohlhaus JR, Sy FS, Stinson N Jr, Ruffin J. Moving toward paradigm-shifting research in health disparities through translational, transformational, and transdisciplinary approaches. Am J Public Health. 2010; 100(Suppl 1): S19S24.
  • 17
    Zerhouni EA. Translational and clinical science–time for a new vision. N Engl J Med. 2005; 353(15): 16211623.
  • 18
    Jones L, Wells K. Strategies for academic and clinician engagement in community-participatory partnered research. JAMA. 2007; 297(4): 407410.
  • 19
    Knoppers BM, Lévesque E. INTRODUCTION: return of research results: how should research results be handled? J Law Med Ethics. 2011; 39(4): 574576.
  • 20
    Knoppers BM, Dam A. Return of Results: Towards a Lexicon? J Law Med Ethics. 2011; 39(4): 577582.
  • 21
    Knoppers BM, Deschenes M, Zawati MH, Tasse AM. Population studies: return of research results and incidental findings Policy Statement. Eur J Hum Genet. 2013; 21(3): 245247.
  • 22
    Halverson C, Ross L. Engaging African-Americans about biobanks and the return of research results. J Commun Genet. 2012; 3(4): 275283.
  • 23
    Haga SB, Beskow LM. Ethical, legal, and social implications of biobanks for genetics research. Adv Genet. 2008; 60: 505544.
  • 24
    Katzmarzyk PT, Malina RM, Perusse L, Rice T, Province MA, Rao DC, Bouchard C. Familial resemblance in fatness and fat distribution. Am J Hum Biol. 2000; 12(3): 395404.
  • 25
    Hong Y, Weisnagel SJ, Rice T, Sun G, Mandel SA, Gu C, Rankinen T, Gagnon J, Leon AS, Skinner JS, et al. Familial resemblance for glucose and insulin metabolism indices derived from an intravenous glucose tolerance test in Blacks and Whites of the HERITAGE Family Study. Clin Genet. 2001; 60(1): 2230.
  • 26
    Shaibi GQ, Konopken Y, Hoppin E, Keller CS, Ortega R, Castro FG. Effects of a culturally grounded community-based diabetes prevention program for obese Latino adolescents. Diabet Educat. 2012; 38(4): 504512.
  • 27
    Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003; 290(14): 18841890.
  • 28
    Castro FG, Alarcon EH. Integrating cultural variables into drug abuse prevention and treatment with racial/ethnic minorities. J Drug Issues. 2002; 32(3): 783811.